Jan. 22, 2024

WRAIR scientists and collaborators identify previously unreported animal reservoirs for Lassa virus in Nigeria

SILVER SPRING, Md. — In collaboration with the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID),

Sept. 13, 2022

Malaria vaccine candidate safe and immunogenic following first-in-human trials

Researchers from the Walter Reed Army Institute of Research (WRAIR) report the malaria vaccine

Jan. 27, 2022

Zika vaccine shows promising results in preclinical studies

A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to

Dec. 16, 2021

Series of preclinical studies supports the Army’s pan-coronavirus vaccine development strategy

A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle

Oct. 19, 2021

New malaria vaccine candidate enters test phase

The World Health Organization recommended the first vaccine for malaria on October 6 for sub-Saharan

Aug. 31, 2021

Koenig assumes command of WRAIR

Col. Chad Koenig assumed responsibility as the 48th commander of the Walter Reed Army Institute of